phase readout
saveNCT07450040: Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma
ENROLLING_BY_INVITATIONupdated 5mo ago
community read0 votes
Sponsor: Eye & ENT Hospital of Fudan University. Phase: . Conditions: ORR, OS, PFS
view source ↗Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that